Hormone Receptor Positive (HR+), HER2-negative Breast Cancer
2 clinical trials · Condition
◉ Watch Hormone Receptor Positive (HR+), HER2-negative Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study (NCT06805812) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2023-05-01 |
| Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD) (NCT04443348) | Laura M. Spring, MD | 2020-12-16 |
Track Hormone Receptor Positive (HR+), HER2-negative Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.